Items
Displaying 1049851-1049900 of 1299939 results.
| Cat.No. | Description | Unit Of Measure |
|---|---|---|
| 45-PH016025-250MG-EA | (S)-2-(Methylamino)-2-phenylbutan-1-ol, | EA |
| 45-PH016063-250MG-EA | 1-(3-(Piperidin-4-yl)benzyl)piperidine, | EA |
| 45-PH016077-500MG-EA | 4-Bromo-1-(bromomethyl)-2-ethylbenzene, | EA |
| 45-PH015903-100MG-EA | (5-Methyl-2-phenyl-1H-indol-3-yl)acetic | EA |
| 45-PH016067-500MG-EA | (4-Amino-2-oxo-1(2H)-pyrimidinyl)acetic | EA |
| 45-PH016024-250MG-EA | 4-Benzyl-5, 6, 7, 8-tetrahydropyrido[4, | EA |
| 45-PH015847-100MG-EA | 2-(6-Methoxypyridin-3-yl)-1H-pyrrolo[2, | EA |
| 45-PH015844-100MG-EA | N-Methyl-4, 5, 6, 7-tetrahydrothieno[2, | EA |
| 45-PH015946-100MG-EA | tert-Butyl 2-(4-methoxybenzyl)-1-oxo-2, | EA |
| 45-PH016002-1G-EA | 2-Chloro-N-(cyclopropylmethyl)-N-{4-[2, | EA |
| 45-B150-1MG-EA | BQ-123, >=99%, sodium salt, lyophilized | EA |
| 45-JRD1058-1G-EA | 2-Chloro-6-p-tolylpyridine-4-carboxylic | EA |
| 45-IDF00149-1G-EA | 2'-Hydroxy-2, 4, 4'-trimethoxychalcone, | EA |
| 45-ANV00255-1G-EA | Ethyl 3-methyl-1H-indole-2-carboxylate, | EA |
| 45-CDS009167-100MG-EA | Discontinued | EA |
| 45-BBO000669-1G-EA | 5-Chloro-3-[(4-methoxyphenyl)methyl]-1, | EA |
| 45-VBP00300-1G-EA | (S)-1-(pyrrolidin-2-ylmethyl)piperidine | EA |
| 45-OTV000945-1G-EA | 6-(4-Isopropylphenyl)-4-oxo-2-thioxo-1, | EA |
| 45-I17002-10UG-EA | Discontinued | EA |
| 45-SAB4200777-100UL-EA | Anti-LbCpf1 antibody, Mouse monoclonal, | EA |
| 45-SAB4200756-100UL-EA | Anti-AsCpf1 antibody, Mouse monoclonal, | EA |
| 45-SAB5600118-100UL-EA | Anti-MYD88 antibody, Rabbit Monoclonal, | EA |
| 45-JRD1073-1G-EA | 2-Phenyl-6-p-tolylpyridine-4-carboxylic | EA |
| 45-IDF00110-1G-EA | 3-Methoxy-4, 2', 5'-trihydroxychalcone, | EA |
| 45-IDF00147-1G-EA | 2'-Hydroxy-2, 3, 5'-trimethoxychalcone, | EA |
| 45-IDF00158-1G-EA | 2'-Hydroxy-3, 4, 5'-trimethoxychalcone, | EA |
| 45-PHB00089-1G-EA | 1-Boc-2, 5-dihydro-3-methyl-1H-pyrrole, | EA |
| 45-PHB00116-1G-EA | 5-Bromo-2-(1, 3-dioxolan-2-yl)thiazole, | EA |
| 45-CBR00119-1G-EA | 2-Methyltetrahydro-2-furancarbonitrile, | EA |
| 45-CDS008086-250MG-EA | Discontinued | EA |
| 45-JRD1190-1G-EA | Methyl 2-(p-tolyloxy)-5-chlorobenzoate, | EA |
| 45-PHB00058-1G-EA | 4-(Hydroxymethyl)-1-methyl-1H-indazole, | EA |
| 45-CBR00027-1G-EA | 3-(3, 5-Dimethylisoxazol-4-yl)propanoic | EA |
| 45-JRD1141-1G-EA | 4-Hydroxy-6-nitroquinoline-3-carboxylic | EA |
| 45-PHB00020-100MG-EA | 6-Boc-2-thia-6-aza-spiro[3.3]heptane-2, | EA |
| 45-BOG00121-1G-EA | 7-Hydroxy-5-methyl-2-phenyl-pyrazolo[1, | EA |
| 45-CBR01695-1G-EA | (1-Methyl-1H-imidazol-5-yl)acetonitrile | EA |
| 45-PHB00003-100MG-EA | cis-8-(Benzylamino)hexahydro-oxazolo[3, | EA |
| 45-398098-1L-EA | [DEA ITEM], Hydriodic acid,contains | EA |
| 45-JRD0860-1G-EA | 3-(4-Bromophenyl)isoxazole-5-carboxylic | EA |
| 45-JRD1025-1G-EA | Discontinued | EA |
| 45-IDF00146-1G-EA | 2'-Hydroxy-2, 3, 4'-trimethoxychalcone, | EA |
| 45-IDF00150-1G-EA | 2'-Hydroxy-2, 4, 5'-trimethoxychalcone, | EA |
| 45-CBR00010-1G-EA | 1-(2, 2-Diethylcyclopropyl)methanamine, | EA |
| 45-CBR00077-1G-EA | 2, 2-Dimethyl-3-morpholin-4-ylpropanal, | EA |
| 45-ADE000277-1G-EA | 2-Amino-5-iodo-pyridine-3-carbaldehyde, | EA |
| 45-CBR00034-1G-EA | 4-[(1-Methylpiperidin-4-yl)oxy]aniline, | EA |
| 45-CBR00104-1G-EA | 2-(4-Chloro-1H-pyrazol-1-yl)ethanamine, | EA |
| 45-CBR00372-1G-EA | 5-(4-Fluorophenyl)-1H-imidazol-2-amine, | EA |
| 45-CBR01728-1G-EA | (1-Methyl-3-morpholin-4-ylpropyl)amine, | EA |
